Tower Research Capital LLC (Trc) Adaptive Biotechnologies Corp Transaction History

Tower Research Capital LLC (Trc)

$3.53 Billion
Q2 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 21,289 shares of ADPT stock, worth $269,518. This represents 0.01% of its overall portfolio holdings.

Number of Shares

21,289

Previous 28,471 25.23%

Holding current value

$269,518

Previous $211,000 17.54%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$6.83 - $12.16 $49,053 - $87,333	-7,182 Reduced 25.23%	21,289 $248,000
Q1 2025 May 15, 2025	BUY	$6.07 - $8.66 $168,691 - $240,670	27,791 Added 4086.91%	28,471 $211,000
Q4 2024 Feb 13, 2025	SELL	$4.37 - $6.78 $66,035 - $102,452	-15,111 Reduced 95.69%	680 $4,000
Q3 2024 Nov 14, 2024	BUY	$3.37 - $5.12 $4,128 - $6,272	1,225 Added 8.41%	15,791 $80,000
Q2 2024 Aug 13, 2024	BUY	$2.34 - $3.96 $31,318 - $53,000	13,384 Added 1132.32%	14,566 $52,000
Q1 2024 May 15, 2024	SELL	$2.88 - $4.8 $225,679 - $376,132	-78,361 Reduced 98.51%	1,182 $3,000
Q4 2023 Feb 13, 2024	BUY	$3.46 - $5.33 $240,231 - $370,067	69,431 Added 686.62%	79,543 $389,000
Q3 2023 Nov 14, 2023	SELL	$5.07 - $8.44 $16,644 - $27,708	-3,283 Reduced 24.51%	10,112 $55,000
Q2 2023 Aug 14, 2023	SELL	$6.19 - $8.78 $158,358 - $224,618	-25,583 Reduced 65.63%	13,395 $89,000
Q1 2023 May 09, 2023	BUY	$7.8 - $10.11 $297,398 - $385,474	38,128 Added 4485.65%	38,978 $344,000
Q4 2022 Feb 10, 2023	SELL	$6.26 - $9.34 $120,592 - $179,925	-19,264 Reduced 95.77%	850 $6,000
Q3 2022 Nov 10, 2022	BUY	$6.5 - $12.67 $106,398 - $207,395	16,369 Added 437.09%	20,114 $143,000
Q2 2022 Aug 15, 2022	SELL	$6.4 - $14.73 $109,408 - $251,809	-17,095 Reduced 82.03%	3,745 $30,000
Q1 2022 May 12, 2022	BUY	$10.12 - $28.9 $202,663 - $578,751	20,026 Added 2460.2%	20,840 $290,000
Q4 2021 Feb 14, 2022	SELL	$25.17 - $36.85 $14,095 - $20,636	-560 Reduced 40.76%	814 $23,000
Q3 2021 Nov 15, 2021	SELL	$30.02 - $39.87 $232,174 - $308,354	-7,734 Reduced 84.91%	1,374 $47,000
Q2 2021 Aug 16, 2021	BUY	$32.22 - $44.59 $246,450 - $341,068	7,649 Added 524.26%	9,108 $372,000
Q1 2021 May 17, 2021	SELL	$37.26 - $67.74 $163,981 - $298,123	-4,401 Reduced 75.1%	1,459 $59,000
Q4 2020 Feb 16, 2021	BUY	$45.01 - $65.47 $219,918 - $319,886	4,886 Added 501.64%	5,860 $347,000
Q3 2020 Nov 16, 2020	SELL	$35.79 - $48.81 $22,619 - $30,847	-632 Reduced 39.35%	974 $47,000
Q2 2020 Aug 13, 2020	BUY	$24.95 - $48.38 $40,069 - $77,698	1,606 New	1,606 $78,000
Q4 2019 Feb 07, 2020	SELL	$24.56 - $32.8 $1,326 - $1,771	-54 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$30.31 - $53.51 $1,636 - $2,889	54 New	54 $2,000

Others Institutions Holding ADPT

# of Institutions

262

Shares Held

149M

Call Options Held

168K

Put Options Held

25.2K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $1.81B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Adaptive Biotechnologies Corp Transaction History